7VLN
NSD2-PWWP1 domain bound with an imidazol-5-yl benzonitrile compound
7VLN の概要
| エントリーDOI | 10.2210/pdb7vln/pdb |
| 分子名称 | Histone-lysine N-methyltransferase NSD2, 4-[5-[4-(aminomethyl)-2,6-dimethoxy-phenyl]-3-methyl-imidazol-4-yl]benzenecarbonitrile (2 entities in total) |
| 機能のキーワード | histone-lysine n-methyltransferase nsd2, transferase |
| 由来する生物種 | Homo sapiens (human) |
| タンパク質・核酸の鎖数 | 3 |
| 化学式量合計 | 45772.91 |
| 構造登録者 | |
| 主引用文献 | Li, N.,Yang, H.,Liu, K.,Zhou, L.,Huang, Y.,Cao, D.,Li, Y.,Sun, Y.,Yu, A.,Du, Z.,Yu, F.,Zhang, Y.,Wang, B.,Geng, M.,Li, J.,Xiong, B.,Xu, S.,Huang, X.,Liu, T. Structure-Based Discovery of a Series of NSD2-PWWP1 Inhibitors. J.Med.Chem., 65:9459-9477, 2022 Cited by PubMed Abstract: Overexpression, point mutations, or translocations of protein lysine methyltransferase NSD2 occur in many types of cancer cells. Therefore, it was recognized as onco-protein and considered as a promising anticancer drug target. NSD2 consists of multiple domains including a SET catalytic domain and two PWWP domains binding to methylated histone proteins. Here, we reported our efforts to develop a series of NSD2-PWWP1 inhibitors, and further structure-based optimization resulted in a potent inhibitor , which has high selectivity toward the NSD2-PWWP1 domain. The detailed biological evaluation revealed that compound can bind to NSD2-PWWP1 and then affect the expression of genes regulated by NSD2. The current discovery will provide a useful chemical probe to the future research in understanding the specific regulation mode of NSD2 by PWWP1 recognition and pave the way to develop potential drugs targeting NSD2 protein. PubMed: 35704853DOI: 10.1021/acs.jmedchem.2c00709 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (3.09 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






